We are live on ! Find out more
ENZY

Enzymotec Ltd
ENZY

Delisted

ENZY was delisted on the 10th of January, 2018.

Back to rankings

34 hedge funds and large institutions have $67.3M invested in Enzymotec Ltd in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

180% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 5

13% more funds holding

Funds holding: 30 → 34 (+4)

23% less capital invested

Capital invested by funds: $88M → $67.3M (-$20.6M)

Holders
34
Holders Change
+4
Holders Change %
+13.33%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
14
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GS
Gagnon Securities
New York
+$2M
2
Goldman Sachs
Goldman Sachs
New York
+$1.66M
3
GA
Gagnon Advisors
New York
+$1.58M
4
LCM
Laurion Capital Management
New York
+$1.56M
5
JHIU
Janus Henderson Investors US
Colorado
+$911K

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$19.9M
2
TM
Tiger Management
New York
-$4.69M
3
Morgan Stanley
Morgan Stanley
New York
-$356K
4
GCP
GSA Capital Partners
United Kingdom
-$329K
5
Millennium Management
Millennium Management
New York
-$73.3K

ENZY Hedge Fund Activity: Q2 2016 in Review

34 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q2 2016, worth a combined $67.3M — down 23% from $88M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ENZY positions and 2 closed out — a net gain of 4 holders — while 14 added to existing stakes and 5 trimmed.

The largest buyer was Gagnon Securities, opening a new position worth an estimated $2M. The largest seller was Visium Asset Management, exiting entirely with an estimated $19.9M sold.

  • 34 institutional investors held Enzymotec Ltd (ENZY) as of Q2 2016, up from 30 in Q1 2016.
  • Funds reported $67.3M of Enzymotec Ltd stock for Q2 2016, down 23% quarter-over-quarter.
  • 6 funds opened new Enzymotec Ltd positions in Q2 2016 and 2 closed out, a net change of +4 holders.
  • The largest Enzymotec Ltd buyer in Q2 2016 was Gagnon Securities, an estimated $2M added.
  • The largest Enzymotec Ltd seller in Q2 2016 was Visium Asset Management, an estimated $19.9M sold.

Based on aggregated 13F filings for Q2 2016.